Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.

NCT00767832 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2009-11-09

No results posted yet for this study

Summary

The purpose of the study is to assess the coagulation changes that occur in patients undergoing elective Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Alexander J Butwick · Stanford University

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00767832 on ClinicalTrials.gov